<DOC>
	<DOC>NCT00235482</DOC>
	<brief_summary>The purpose of this study is to determine the safety of an injection of coxsackievirus A21 into a melanoma tumour, and also to see if there is a tumour response.</brief_summary>
	<brief_title>Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma</brief_title>
	<detailed_description>Coxsackievirus A21, a naturally occurring enterovirus, has shown that in vivo it can infect and lyse melanoma. This study is to assess safety of a single intratumoural injection of the virus into an accessible subcutaneous melanoma metastasis.</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Coxsackievirus Infections</mesh_term>
	<criteria>stage IV melanoma (AJCC classification) minimum of 2 sc metastases failure or refusal of standard chemotherapy ECOG score of 0 or 1 other metastatic CNS disease ocular or mucosal melanoma immunodeficiency splenectomy other</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>